The Quest for an Efficacious Antiviral for Respiratory Syncytial Virus (Q35115949)

6 August 2017

1 reference

title

The quest for an efficacious antiviral for respiratory syncytial virus (English)

1 reference

6 August 2017

The Quest for an Efficacious Antiviral for Respiratory Syncytial Virus (English)

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

28 December 2023

author name string

Paul F. Torrence

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12718405

28 December 2023

Linda D. Powell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12718405

28 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12718405

28 December 2023

publication date

1 November 2002

1 reference

full work available at URL

6 August 2017

http://journals.sagepub.com/doi/pdf/10.1177/095632020201300601

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Antiviral Chemistry & Chemotherapy

28 December 2023

published in

1 reference

6 August 2017

13

1 reference

6 August 2017

6

1 reference

6 August 2017

325-344

1 reference

Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease

6 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Chemistry and biochemistry of 2',5'-oligoadenylate-based antisense strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Oligonucleotide therapeutics for hematologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Guanine-rich oligonucleotide modified at the 5' terminal by dimethoxytrityl residue inhibits HIV-1 replication by specific interaction with the envelope glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Phosphorodiamidate morpholino antisense oligomers inhibit expression of human cytochrome P450 3A4 and alter selected drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Influence of respiratory syncytial virus infection on cytokine and inflammatory responses in allergic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Antiproliferative activity of G-rich oligonucleotides correlates with protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

2'-5' Oligoadenylate synthetase plays a critical role in interferon-gamma inhibition of respiratory syncytial virus infection of human epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Binding of phosphorothioate oligodeoxynucleotides to basic fibroblast growth factor, recombinant soluble CD4, laminin and fibronectin is P-chirality independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Comparison of the base pairing properties of a series of nitroazole nucleobase analogs in the oligodeoxyribonucleotide sequence 5'-d(CGCXAATTYGCG)-3'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Respiratory viruses and chronic rejection in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Community respiratory virus infections following lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Antagonism of 2-5 A-mediated inhibition of protein synthesis in intact cells by 2',5'-(pA)3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

HIV entry and its inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Respiratory syncytial virus infections in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Respiratory syncytial virus: reverse genetics and vaccine strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Synthesis and antiviral and enzymatic studies of certain 3-deazaguanines and their imidazolecarboxamide precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Ribavirin's antiviral mechanism of action: lethal mutagenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Antimetabolic activities of 2-fluoro-L-histidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

2-5A-dependent RNase molecules dimerize during activation by 2-5A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Early ribavarin treatment of bronchiolitis: effect on long-term respiratory morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Implications of high-affinity hybridization by locked nucleic acid oligomers for inhibition of human telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Respiratory syncytial virus infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Ribavirin: a clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Management of respiratory syncytial virus with lower respiratory tract infection in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Myb targeted therapeutics for the treatment of human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

The prospects for antisense therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Synthesis and antiviral activity of certain carbamoylpyrrolopyrimidine and pyrazolopyrimidine nucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Paramyxovirus accessory proteins as interferon antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Quasispecies, error catastrophe, and the antiviral activity of ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

The interferon antiviral response: from viral invasion to evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Respiratory syncytial virus infection: clinical features, management, and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Prevention of respiratory syncytial virus infections in high-risk infants by monoclonal antibody (palivizumab).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Nosocomial respiratory syncytial virus infections: the "Cold War" has not ended

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Activation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Synthesis and antiviral evaluation of a mutagenic and non-hydrogen bonding ribonucleoside analogue: 1-beta-D-Ribofuranosyl-3-nitropyrrole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

The efficacy of intranasal interferon alpha-2a in respiratory syncytial virus infection in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Biologically active oligodeoxyribonucleotides. 5. 5'-End-substituted d(TGGGAG) possesses anti-human immunodeficiency virus type 1 activity by forming a G-quadruplex structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Antiproliferative effects of steric blocking phosphorodiamidate morpholino antisense agents directed against c-myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

RFI-641, a potent respiratory syncytial virus inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Production of interferon in respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Viral infections in immunocompromised patients: what's new with respiratory viruses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Respective role of each of the purine N7 nitrogens of 5'-O-triphosphoadenylyl(2'----5')adenylyl(2'----5')adenosine in binding to and activation of the RNase L of mouse cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Developing G-quartet oligonucleotides as novel anti-HIV agents: focus on anti-HIV drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Stability-activity relationships of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors. A basis for anti-HIV drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Structure-activity of inhibition of HIV-1 integrase and virus replication by G-quartet oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Mechanism of inhibition of HIV-1 integrase by G-tetrad-forming oligonucleotides in Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Respiratory syncytial virus vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Phosphorothioate analogues of 2',5'-oligoadenylate. Activation of 2',5'-oligoadenylate-dependent endoribonuclease by 2',5'-phosphorothioate cores and 5'-monophosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatically synthesized 2',5'-phosphorothioate dimer and trimer: unequivocal structural assignment and activation of 2',5'-oligoadenylate-dependent endoribonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Viruses and interferon: a fight for supremacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Quadruplex structures in nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Management of respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Synthesis and antitumor activity of ribavirin imidates. A new facile synthesis of ribavirin amidine (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

8-Methyladenosine-substituted analogues of 2-5A: synthesis and their biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Ribavirin Induces Error-Prone Replication of GB Virus B in Primary Tamarin Hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Targeted therapy of respiratory syncytial virus in African green monkeys by intranasally administered 2-5A antisense

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Antisense oligonucleotides: promise and reality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Phosphorylation of 2-5A core 5'-diphosphate to 2-5A in mouse L cell extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Catalytic cleavage of an RNA target by 2-5A antisense and RNase L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Correlation between respiratory syncytial virus genotype and severity of illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Respiratory syncytial virus: recent progress towards the discovery of effective prophylactic and therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Respiratory syncytial virus replication in human lung epithelial cells: inhibition by tumor necrosis factor alpha and interferon beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on tolerance induction in SJL mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

1,2,4-Triazole amino nucleosides. 1-.beta.-D-3'-amino-3'-deoxyribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

The discovery of RFI-641 as a potent and selective inhibitor of the respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Potent inhibition of respiratory syncytial virus replication using a 2-5A-antisense chimera targeted to signals within the virus genomic RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

An update on respiratory syncytial virus antiviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

In vivo evaluation of a morpholino antisense oligomer directed against tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Studies on the mechanism of the antiviral activity of ribavirin against reovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

RFI-641 inhibits entry of respiratory syncytial virus via interactions with fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Synthesis and biological activity of some nucleosides resembling guanosine: imidazo(1,2-alpha)pyrimidine nucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Selective mRNA degradation by antisense oligonucleotide-2,5A chimeras: involvement of RNase H and RNase L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

The limited role of the human interferon system response to respiratory syncytial virus challenge: analysis and comparison to influenza virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Respiratory syncytial virus infections--an underdiagnosed entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Synthesis and evaluation of 5-amino-1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine and certain related nucleosides as inhibitors of purine nucleoside phosphorylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Replacement of the ribofuranose oxygen of 2-5A derivatives by methylene: synthesis of an aristeromycin analogue of 2-5A core 5'-monophosphate (5'-O-phosphoryladenylyl)(2'----5')adenyl(2'----5')adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Role of the vaccinia virus E3L and K3L gene products in rescue of VSV and EMCV from the effects of IFN-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Ribavirin: An antiviral agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Fascination with 2-5A-Dependent RNase: A Unique Enzyme That Functions in Interferon Action*

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Selective RNA cleavage by isolated RNase L activated with 2-5A antisense chimeric oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Skin allograft rejection is suppressed in mice lacking the antiviral enzyme, 2',5'-oligoadenylate-dependent RNase L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Novel nucleoside inhibitors of guanosine metabolism as antitumor agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Combination treatment for chronic hepatitis C: what is the role of ribavirin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Nucleosides of 4-substituted imidazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Synthesis and antiviral activity of certain thiazole C-nucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Phosphorothioate antisense oligodeoxynucleotides: questions of specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

The experimental use of antisense oligonucleotides: a guide for the perplexed

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

The synthesis and antiviral activity of 4-fluoro-1-beta-D-ribofuranosyl-1H-pyrazole-3-carboxamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Mechanism of selective inhibition of respiratory syncytial virus by a benzodithiin compound (RD3-0028).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Pharmacokinetics of a benzodithiin (RD3-0028) following aerosol treatment in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Morpholino antisense oligomers: the case for an RNase H-independent structural type

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Morpholino antisense oligomers: design, preparation, and properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Treatment of respiratory syncytial virus infection with recombinant interferon alfa-2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Management of infections caused by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Mechanisms of action of ribavirin in antiviral therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Interferon alfa, infectious virus, and virus antigen secretion in respiratory syncytial virus infections of graded severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Comparison of efficacy of antisense oligomers directed toward TNF-alpha in helper T and macrophage cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Effect of TNF-alpha antisense oligomers on cytokine production by primary murine alveolar macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Effect of ribavirin on macromolecular synthesis in vesicular stomatitis virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Antisense oligodeoxynucleotides as clinical therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

5'-O-Monophosphoryladenylyl(2' goes to 5')adenylyl(2' goes to 5')adenosine is an antagonist of the action of 5'-O-triphosphoryladenylyl-(2' goes to 5')adenylyl(2' goes to 5')adenosine and double-stranded RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Oligonucleotide structural parameters that influence binding of 5'-O-triphosphoadenylyl-(2'----5')-adenylyl-(2'----5')-adenosine to the 5'-O-triphosphoadenylyl-(2'----5')-adenylyl-(2'----5')-adenosine dependent endoribonuclease: chain length, phosph

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Targeting RNA for degradation with a (2'-5')oligoadenylate-antisense chimera

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Accelerating RNA decay through intervention of RNase L: alternative synthesis of composite 2',5'-oligoadenylate-antisense

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Recruiting the 2-5A system for antisense therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Novel pathways in the pathogenesis of respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Synthesis and RNAse L binding and activation of a 2-5A-(5')-DNA-(3')-PNA chimera, a novel potential antisense molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

2,5-oligoadenylate-peptide nucleic acids (2-5A-PNAs) activate RNase L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Incorporation of a 4-hydroxy-N-acetylprolinol nucleotide analogue improves the 3'-exonuclease stability of 2'-5'-oligoadenylate-antisense conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Conformational analysis of nucleoside and nucleotide antibiotics prossessing five-membered base rings. A comparison of the glycosyl barrier for purine, pyrimidine and imidazole rings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Preventive and therapeutic strategies for respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Novel anti-respiratory syncytial(RS) viral compounds: benzodithiin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Synthesis and biological activity of 5-thiobredinin and certain related 5-substituted imidazole-4-carboxamide ribonucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

CL387626 exhibits marked and unusual antiviral activity against respiratory syncytial virus in tissue culture and in cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Structural characterization of the human respiratory syncytial virus fusion protein core

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

DNA antisense therapy for asthma in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020201300601

Protection of hu-PBL-SCID/beige mice from HIV-1 infection by a 6-mer modified oligonucleotide, R-95288

21 January 2018

4

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Journal of Pharmacology and Experimental Therapeutics

28 December 2023

7

292

921

Arora V

2000

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide

28 December 2023

17

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Alpha-2A-interferon for treatment of bronchiolitis caused by respiratory syncytial virus.

28 December 2023

26

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

American Journal of Medicine

28 December 2023

28

85

165

Clumeck N

1988

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Discrimination between ribonuclease H- and ribonuclease L-mediated RNA degradation by 2'-O-methylated 2-5A-antisense oligonucleotides

28 December 2023

32

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

A bipartite model of 2-5A-dependent RNase L

28 December 2023

37

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Antisense morpholino oligonucleotide analog induces missplicing of C-myc mRNA

28 December 2023

50

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Analogues and analogue inhibitors of ppp(A2'p)nA. Their stability and biological activity

28 December 2023

61

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Synthesis of C-nucleosides. Part 14. 5(3)-Glycosyl-1,2,4-triazole-3(5) carboxamides as analogues of ribavirin

28 December 2023

67

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Protein, Nucleic Acid, Enzyme

28 December 2023

73

28

801

Imai J

1983

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Synthesis and biological activity of 5'-capped derivatives of 5'-triphosphoadenylyl(2'----5')adenylyl(2'----5')adenosine

28 December 2023

74

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Synthesis and biological activity of tubercidin analogues of ppp5'A2'p(5'A2'p)n5'A

28 December 2023

77

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Phosphorothioate oligodeoxynucleotides: antisense or anti-protein?

28 December 2023

99

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

2',5'-Oligoadenylate:antisense chimeras--synthesis and properties

28 December 2023

106

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Synthesis and biological activity of a fluorescent analogue of 2-5A

28 December 2023

107

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Synthesis and biological activities of oligo(8-bromoadenylates) as analogues of 5'-O-triphosphoadenylyl(2'----5')adenylyl(2'----5')adenosine

28 December 2023

109

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Synthesis and properties of second-generation 2-5A-antisense chimeras with enhanced resistance to exonucleases

28 December 2023

111

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Detection of alpha-interferon in nasopharyngeal secretions and sera in children infected with respiratory syncytial virus.

28 December 2023

125

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation

28 December 2023

132

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Molecular mechanisms of action of ribavirin

28 December 2023

133

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Induction of interferon in human leukocyte cultures by natural pathogenic respiratory viruses

28 December 2023

136

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Phosphorothioate oligodeoxyribonucleotides inhibit ribonuclease L thereby disabling a mechanism of interferon action

28 December 2023

139

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Respiratory syncytial virus prophylaxis—the story so far

28 December 2023

158

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Ciba Foundation Symposium

28 December 2023

168

209

79

Stein CA

1997

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides

28 December 2023

171

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

A specificity comparison of four antisense types: morpholino, 2'-O-methyl RNA, DNA, and phosphorothioate DNA

28 December 2023

172

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Efficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in immunosuppressed mice.

28 December 2023

175

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Morpholino and phosphorothioate antisense oligomers compared in cell-free and in-cell systems

28 December 2023

178

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

In vitro efficacy of morpholino-modified antisense oligomers directed against tumor necrosis factor-alpha mRNA

28 December 2023

184

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

A new and potent 2-5A analogue which does not require a 5'-polyphosphate to activate mouse L-cell RNase L

28 December 2023

191

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

28 December 2023

201

53

99

Van Woensel JB KJ

2001

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

2-5A-PNA complexes: a novel class of antisense compounds

28 December 2023

202

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

A comparison of guanosine-quartet inhibitory effects versus cytidine homopolymer inhibitory effects on rat neointimal formation

28 December 2023

208

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Convergent synthesis of ribonuclease L-active 2',5'-oligoadenylate-peptide nucleic acids

28 December 2023

209

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Current clinical topics in infectious diseases

28 December 2023

211

20

232

Whimbey E

2000

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L

28 December 2023

217

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Chinese Journal of Tuberculosis and Respiratory Diseases

28 December 2023

218

25

341

Xue Q

2002

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

Impact of RNase L overexpression on viral and cellular growth and death

28 December 2023

224

1 reference

https://api.crossref.org/works/10.1177/095632020201300601

28 December 2023

Identifiers

1 reference

6 August 2017

1 reference